wersja polska  
Mediton - Publishing House
Start page  Journals  Books  Conferences  News  Mediton  Contact   
   Journals
print this
   Allergy Asthma Immunology - archive  

Allergy Asthma Immunology
     Archive
     Editorial staff
     Editorial board
     For authors
     Subscription
Otorhinolaryngology
Allergology Review



 Search in articles:
  Authority of Polish Society of Allergology




vol 6. no 2. June 2001  
 TABLE OF CONTENT

 Original articles
Clinical efficacy of autovaccine in the treatment of infectious nonatopic asthma and COPD - double blind placebo controlled trial
Józef Hałasa, Maciej Hałasa, Wiesława Wojciechowska, Izabela Podkowińska, Elżbieta Kucharska

A total of 24 patients with nonatopic infectious asthma and COPD, demonstrating symptoms of infection-induced exacerbations were treated with autovaccine in the double blind, placebo controlled trial.
Autovaccine was prepared from autologic bacterial strains repeatedly isolated from the lower airways. Together with the strains commonly recognized as pathogenic in the airways (Haemophilus influenzae or Streptococcus pneumoniae), we also included those of so called physiologic strains (Streptococcus viridans or Neisseria species), which provoked early (after 15 min.), delayed (after 8-10 h) or late (after 24-48 h) skin test reactions in studied patients.
Analysis of the therapeutical effect in regard of both subjective and objective clinical parameters suggests high efficiency of autovaccine in treatment of nonatopic asthma and COPD.
In conclusion, the effect of treatment strongly depends on the quality of the autovaccine used. It has to include not only bacterial strains commonly recognized as pathogenic, but also those so called "physiologic" which induce allergic reactions in a number of patients.
Alergia Astma Immunologia, 2001, 6(2), 109-113


keywords: astma, POCH, bakterie, autoszczepionka, asthma, COPD, bacterial strains, autovaccine

pages: from 109 to 113



estimated time of download (90 kB)
broadband speed:561282565121024[kbps]
time:197422[sec]


You need to have Adobe Acrobat Reader to view the PDF file. It's free. If you don't have the Adobe Acrobat Reader plugin yet, you can get it HERE.


Start page | Journals | Books | Conferences | News | Mediton | Contact

Copyright © 1996-2020 Mediton Publishing House | All rights reserved.